Review



designer drugs dreadd agonist 21 dihydrochloride  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Tocris designer drugs dreadd agonist 21 dihydrochloride
    Designer Drugs Dreadd Agonist 21 Dihydrochloride, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dreadd+agonist+21+dihydrochloride/DREADD+agonist+21+dihydrochloride/pmc12947416-101-10-17
    Average 94 stars, based on 20 article reviews
    designer drugs dreadd agonist 21 dihydrochloride - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    Activity Assay:

    Article Title: A top-down insular cortex circuit crucial for non-nociceptive fear learning
    Article Snippet: .. To examine calcium activity of CGRP PBN neurons while chemogenetically inhibiting pIC →PBN neurons, DREADD agonist 21 dihydrochloride (C21; Tocris, #6422; working solution of 0.2 mg/ml and stock of 10 mg/ml) was administered via intraperitoneal injection at a dose of 1 mg/kg. ..

    Article Title: A top-down insular cortex circuit crucial for non-nociceptive fear learning
    Article Snippet: .. To record calcium activity of CGRP PBN neurons while inhibiting pIC →PBN neurons chemo-genetically, DREADD agonist 21 dihydrochloride (C21; Tocris, #6422; 0.2 mg/ml working solution, 10 mg/ml stock) was administered via i.p. injection at a dose of 1 mg/kg. ..

    Article Title: A top-down insular cortex circuit crucial for non-nociceptive fear learning.
    Article Snippet: .. To examine calcium activity of CGRPPBN neurons while chemogenetically inhibiting pIC→PBN neurons, DREADD agonist 21 dihydrochloride (C21; Tocris, #6422; working solution of 0.2 mg/ml and stock of 10 mg/ml) was administered via intraperitoneal injection at a dose of 1 mg/kg. ..

    Injection:

    Article Title: A top-down insular cortex circuit crucial for non-nociceptive fear learning
    Article Snippet: .. To examine calcium activity of CGRP PBN neurons while chemogenetically inhibiting pIC →PBN neurons, DREADD agonist 21 dihydrochloride (C21; Tocris, #6422; working solution of 0.2 mg/ml and stock of 10 mg/ml) was administered via intraperitoneal injection at a dose of 1 mg/kg. ..

    Article Title: A top-down insular cortex circuit crucial for non-nociceptive fear learning
    Article Snippet: .. To record calcium activity of CGRP PBN neurons while inhibiting pIC →PBN neurons chemo-genetically, DREADD agonist 21 dihydrochloride (C21; Tocris, #6422; 0.2 mg/ml working solution, 10 mg/ml stock) was administered via i.p. injection at a dose of 1 mg/kg. ..

    Article Title: Hypothalamic recurrent inhibition regulates functional states of stress effector neurons
    Article Snippet: .. In DREADD-expressing animals, DREADD agonist 21 dihydrochloride (C21; TOCRIS 6422) was delivered via intraperitoneal injection at 3 mg/kg dissolved in saline. .. Astressin (Tocris Bioscence, Cat. No. 1606) was dissolved in saline.

    Article Title: A top-down insular cortex circuit crucial for non-nociceptive fear learning.
    Article Snippet: .. To examine calcium activity of CGRPPBN neurons while chemogenetically inhibiting pIC→PBN neurons, DREADD agonist 21 dihydrochloride (C21; Tocris, #6422; working solution of 0.2 mg/ml and stock of 10 mg/ml) was administered via intraperitoneal injection at a dose of 1 mg/kg. ..

    Sterility:

    Article Title: Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia
    Article Snippet: .. For the Designer Receptor Exclusively Activated by Designer Drugs (DREADD) manipulation before behavioral experiments, DREADD agonist 21 dihydrochloride (#6422, Tocris, USA, C21) was freshly dissolved in 0.9% sterile saline and intraperitoneally administered 3 weeks after DREADD protein expression and 30 min before behavioral tests were performed at a dose of 2 mg/kg. ..

    Article Title: Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia.
    Article Snippet: .. For the Designer Receptor Exclusively Activated by Designer Drugs (DREADD) manipulation before behavioral experiments, DREADD agonist 21 dihydrochloride (#6422, Tocris, USA, C21) was freshly dissolved in 0.9% sterile saline and intraperitoneally administered 3 weeks after DREADD protein expression and 30 min before behavioral tests were performed at a dose of 2 mg/kg. ..

    Saline:

    Article Title: Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia
    Article Snippet: .. For the Designer Receptor Exclusively Activated by Designer Drugs (DREADD) manipulation before behavioral experiments, DREADD agonist 21 dihydrochloride (#6422, Tocris, USA, C21) was freshly dissolved in 0.9% sterile saline and intraperitoneally administered 3 weeks after DREADD protein expression and 30 min before behavioral tests were performed at a dose of 2 mg/kg. ..

    Article Title: Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia.
    Article Snippet: .. For the Designer Receptor Exclusively Activated by Designer Drugs (DREADD) manipulation before behavioral experiments, DREADD agonist 21 dihydrochloride (#6422, Tocris, USA, C21) was freshly dissolved in 0.9% sterile saline and intraperitoneally administered 3 weeks after DREADD protein expression and 30 min before behavioral tests were performed at a dose of 2 mg/kg. ..

    Article Title: Hypothalamic recurrent inhibition regulates functional states of stress effector neurons
    Article Snippet: .. In DREADD-expressing animals, DREADD agonist 21 dihydrochloride (C21; TOCRIS 6422) was delivered via intraperitoneal injection at 3 mg/kg dissolved in saline. .. Astressin (Tocris Bioscence, Cat. No. 1606) was dissolved in saline.

    Expressing:

    Article Title: Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia
    Article Snippet: .. For the Designer Receptor Exclusively Activated by Designer Drugs (DREADD) manipulation before behavioral experiments, DREADD agonist 21 dihydrochloride (#6422, Tocris, USA, C21) was freshly dissolved in 0.9% sterile saline and intraperitoneally administered 3 weeks after DREADD protein expression and 30 min before behavioral tests were performed at a dose of 2 mg/kg. ..

    Article Title: Activation of basolateral amygdala to anterior cingulate cortex circuit alleviates MK-801 induced social and cognitive deficits of schizophrenia.
    Article Snippet: .. For the Designer Receptor Exclusively Activated by Designer Drugs (DREADD) manipulation before behavioral experiments, DREADD agonist 21 dihydrochloride (#6422, Tocris, USA, C21) was freshly dissolved in 0.9% sterile saline and intraperitoneally administered 3 weeks after DREADD protein expression and 30 min before behavioral tests were performed at a dose of 2 mg/kg. ..



    Similar Products

    94
    Tocris designer drugs dreadd agonist 21 dihydrochloride
    Designer Drugs Dreadd Agonist 21 Dihydrochloride, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dreadd+agonist+21+dihydrochloride/DREADD+agonist+21+dihydrochloride/pmc12947416-101-10-17
    Average 94 stars, based on 1 article reviews
    designer drugs dreadd agonist 21 dihydrochloride - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Tocris dreadd agonist 21 c21 c21 dihydrochloride
    Dreadd Agonist 21 C21 C21 Dihydrochloride, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dreadd+agonist+21+dihydrochloride/DREADD+agonist+21+dihydrochloride/pm41118757-901-0-6
    Average 94 stars, based on 1 article reviews
    dreadd agonist 21 c21 c21 dihydrochloride - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Tocris dreadd agonist 21 dihydrochloride
    Dreadd Agonist 21 Dihydrochloride, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dreadd+agonist+21+dihydrochloride/DREADD+agonist+21+dihydrochloride/bio_rxiv__2025__09__03__673779-197-3-8
    Average 94 stars, based on 1 article reviews
    dreadd agonist 21 dihydrochloride - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Tocris compound 21
    Compound 21, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dreadd+agonist+21+dihydrochloride/DREADD+agonist+21+dihydrochloride/pmc12391478-349-23-26
    Average 94 stars, based on 1 article reviews
    compound 21 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    Tocris dreadd agonist 21 c21
    A) Diagram of imaging cannula for in vivo 2-photon imaging of DG. B) Diagram of focal plane for GCL (left) and hilar (left) imaging (top). Time-averaged 2-photon images of GCL and hilus (bottom). C) Schematic of imaging setup with virtual reality. The mouse is head-fixed running on top of a floating ball while the virtual environment is projected on a dome that surrounds the mouse. D). Image of familiar virtual reality environment. E) Diagram of viral injections for chemogenetic activation of VGluT3+ cells and GCaMP imaging of MCs/GCs (top). Representative fluorescence traces from MCs during baseline (left) and after system injection of <t>C21</t> (right) – significant transients are highlighted in red. F) Group data on Ca 2+ transient frequency during baseline and C21 sessions for MCs and GCs (MCs: baseline n=274 cells, 7 mice, C21 n=257 cells, 7 mice; GCs: baseline n=484 cells, 3 mice, C21 n=412 cells, 3 mice; ***p<0.001 Mann-Whitney U test). G) Spatial tuning heatmaps for spatially tuned mossy cells in baseline and C21 sessions. Cells are sorted by the location of the peak of their spatial tuning curves. H) Group data showing proportion of spatially tuned cells in each mouse during baseline and C21 sessions (n=5 mice; *p<0.05 t-test, mean± s.e.m.). I) Group data showing MC place field width during baseline and C21 sessions (baseline, n=88 cells, 5 mice; C21, n=54 cells, 5 mice; mean± s.e.m.).
    Dreadd Agonist 21 C21, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dreadd+agonist+21+dihydrochloride/DREADD+agonist+21+dihydrochloride/bio_rxiv__2025__07__09__663808-282-11-17
    Average 94 stars, based on 1 article reviews
    dreadd agonist 21 c21 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    90
    Tocris dreadd agonist 21 dihydrochloride c21
    A) Diagram of imaging cannula for in vivo 2-photon imaging of DG. B) Diagram of focal plane for GCL (left) and hilar (left) imaging (top). Time-averaged 2-photon images of GCL and hilus (bottom). C) Schematic of imaging setup with virtual reality. The mouse is head-fixed running on top of a floating ball while the virtual environment is projected on a dome that surrounds the mouse. D). Image of familiar virtual reality environment. E) Diagram of viral injections for chemogenetic activation of VGluT3+ cells and GCaMP imaging of MCs/GCs (top). Representative fluorescence traces from MCs during baseline (left) and after system injection of <t>C21</t> (right) – significant transients are highlighted in red. F) Group data on Ca 2+ transient frequency during baseline and C21 sessions for MCs and GCs (MCs: baseline n=274 cells, 7 mice, C21 n=257 cells, 7 mice; GCs: baseline n=484 cells, 3 mice, C21 n=412 cells, 3 mice; ***p<0.001 Mann-Whitney U test). G) Spatial tuning heatmaps for spatially tuned mossy cells in baseline and C21 sessions. Cells are sorted by the location of the peak of their spatial tuning curves. H) Group data showing proportion of spatially tuned cells in each mouse during baseline and C21 sessions (n=5 mice; *p<0.05 t-test, mean± s.e.m.). I) Group data showing MC place field width during baseline and C21 sessions (baseline, n=88 cells, 5 mice; C21, n=54 cells, 5 mice; mean± s.e.m.).
    Dreadd Agonist 21 Dihydrochloride C21, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dreadd+agonist+21+dihydrochloride/dreadd+agonist+21++c21+/pm40344067-402-10-17
    Average 90 stars, based on 1 article reviews
    dreadd agonist 21 dihydrochloride c21 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    A) Diagram of imaging cannula for in vivo 2-photon imaging of DG. B) Diagram of focal plane for GCL (left) and hilar (left) imaging (top). Time-averaged 2-photon images of GCL and hilus (bottom). C) Schematic of imaging setup with virtual reality. The mouse is head-fixed running on top of a floating ball while the virtual environment is projected on a dome that surrounds the mouse. D). Image of familiar virtual reality environment. E) Diagram of viral injections for chemogenetic activation of VGluT3+ cells and GCaMP imaging of MCs/GCs (top). Representative fluorescence traces from MCs during baseline (left) and after system injection of C21 (right) – significant transients are highlighted in red. F) Group data on Ca 2+ transient frequency during baseline and C21 sessions for MCs and GCs (MCs: baseline n=274 cells, 7 mice, C21 n=257 cells, 7 mice; GCs: baseline n=484 cells, 3 mice, C21 n=412 cells, 3 mice; ***p<0.001 Mann-Whitney U test). G) Spatial tuning heatmaps for spatially tuned mossy cells in baseline and C21 sessions. Cells are sorted by the location of the peak of their spatial tuning curves. H) Group data showing proportion of spatially tuned cells in each mouse during baseline and C21 sessions (n=5 mice; *p<0.05 t-test, mean± s.e.m.). I) Group data showing MC place field width during baseline and C21 sessions (baseline, n=88 cells, 5 mice; C21, n=54 cells, 5 mice; mean± s.e.m.).

    Journal: bioRxiv

    Article Title: A novel, evolutionarily conserved inhibitory circuit selectively regulates dentate gyrus mossy cell function

    doi: 10.1101/2025.07.09.663808

    Figure Lengend Snippet: A) Diagram of imaging cannula for in vivo 2-photon imaging of DG. B) Diagram of focal plane for GCL (left) and hilar (left) imaging (top). Time-averaged 2-photon images of GCL and hilus (bottom). C) Schematic of imaging setup with virtual reality. The mouse is head-fixed running on top of a floating ball while the virtual environment is projected on a dome that surrounds the mouse. D). Image of familiar virtual reality environment. E) Diagram of viral injections for chemogenetic activation of VGluT3+ cells and GCaMP imaging of MCs/GCs (top). Representative fluorescence traces from MCs during baseline (left) and after system injection of C21 (right) – significant transients are highlighted in red. F) Group data on Ca 2+ transient frequency during baseline and C21 sessions for MCs and GCs (MCs: baseline n=274 cells, 7 mice, C21 n=257 cells, 7 mice; GCs: baseline n=484 cells, 3 mice, C21 n=412 cells, 3 mice; ***p<0.001 Mann-Whitney U test). G) Spatial tuning heatmaps for spatially tuned mossy cells in baseline and C21 sessions. Cells are sorted by the location of the peak of their spatial tuning curves. H) Group data showing proportion of spatially tuned cells in each mouse during baseline and C21 sessions (n=5 mice; *p<0.05 t-test, mean± s.e.m.). I) Group data showing MC place field width during baseline and C21 sessions (baseline, n=88 cells, 5 mice; C21, n=54 cells, 5 mice; mean± s.e.m.).

    Article Snippet: For both hM3Dq and hM4Di experiments, mice received i.p. injections of DREADD agonist 21 (C21) (3 mg/kg; Tocris Cat No. 6422) 30 minutes before the start of imaging sessions.

    Techniques: Imaging, In Vivo, Activation Assay, Fluorescence, Injection, MANN-WHITNEY

    A) Example traces of GCaMP fluorescence traces from MCs (black, top), animal’s position in VR (gray, middle) and running velocity (green, bottom). B) Bar graph showing animal’s average running velocity during baseline and C21 sessions (n=5 mice; mean± s.e.m.). C) Bar graph showing total distance travelled during 12-minute imaging session under baseline and C21 conditions, mean± s.e.m.. D) Graph showing the activity-velocity correlation coefficient for MCs during baseline and C21 sessions (baseline, n=181 cells, 5 mice; C21, n = 150 cells, 5 mice; *p<0.05 Mann-Whitney U test). E) Histogram showing distribution of activity-velocity correlation lags for MCs during baseline and C21 sessions (baseline, n=181 cells, 5 mice; C21, n = 150 cells, 5 mice; *p<0.05 Kolmogorov-Smirnov test on distributions).

    Journal: bioRxiv

    Article Title: A novel, evolutionarily conserved inhibitory circuit selectively regulates dentate gyrus mossy cell function

    doi: 10.1101/2025.07.09.663808

    Figure Lengend Snippet: A) Example traces of GCaMP fluorescence traces from MCs (black, top), animal’s position in VR (gray, middle) and running velocity (green, bottom). B) Bar graph showing animal’s average running velocity during baseline and C21 sessions (n=5 mice; mean± s.e.m.). C) Bar graph showing total distance travelled during 12-minute imaging session under baseline and C21 conditions, mean± s.e.m.. D) Graph showing the activity-velocity correlation coefficient for MCs during baseline and C21 sessions (baseline, n=181 cells, 5 mice; C21, n = 150 cells, 5 mice; *p<0.05 Mann-Whitney U test). E) Histogram showing distribution of activity-velocity correlation lags for MCs during baseline and C21 sessions (baseline, n=181 cells, 5 mice; C21, n = 150 cells, 5 mice; *p<0.05 Kolmogorov-Smirnov test on distributions).

    Article Snippet: For both hM3Dq and hM4Di experiments, mice received i.p. injections of DREADD agonist 21 (C21) (3 mg/kg; Tocris Cat No. 6422) 30 minutes before the start of imaging sessions.

    Techniques: Fluorescence, Imaging, Activity Assay, MANN-WHITNEY

    A) Images of familiar (left) and novel (right) virtual environments (top). Schematic of the layout and reward location for familiar and novel linear virtual environments (bottom). B) Schematic of viral injections for chemogenetic inhibition of VgluT3+ interneurons and imaging of MCs/GCs (left). Experimental timeline for chemogenetic inhibition during contextual switching paradigm (right). C) Group data showing Ca 2+ transient frequency during baseline and C21 sessions for MCs and GCs (MCs: baseline, n=312 cells, 5 mice, C21 n=271 cells, 5 mice; GCs: baseline n=407 cells, 2 mice, C21 n=550 cells, 2 mice; ***p<0.001, **p<0.01 Mann-Whitney U test). D) Spatial heatmaps of MCs with a significant place field in either the familiar or novel context during baseline and C21 sessions. Cells were sorted by the peak of their spatial tuning curve in the familiar context. E) Group data showing tuning curve correlations for within context (FF) and between context (FN) comparisons during baseline and C21 sessions (baseline n=167 cells, 3 mice; C21 n=155 cells, 3 mice; ***p<0.001 Kruskal-Wallis test). F) Graph showing the average magnitude of difference in correlation (1′ stability) between FF and FN comparisons for baseline and C21 sessions (baseline n=167 cells, 3 mice; C21 n=155 cells, 3 mice; *p<0.05 t-test; mean± s.e.m.). G) Plot showing proportion of MCs baseline and C21 conditions that exhibit a decrease, increase or no change in tuning curve correlation from FF to FN (baseline n=167 cells, 3 mice; C21 n=155 cells, 3 mice).

    Journal: bioRxiv

    Article Title: A novel, evolutionarily conserved inhibitory circuit selectively regulates dentate gyrus mossy cell function

    doi: 10.1101/2025.07.09.663808

    Figure Lengend Snippet: A) Images of familiar (left) and novel (right) virtual environments (top). Schematic of the layout and reward location for familiar and novel linear virtual environments (bottom). B) Schematic of viral injections for chemogenetic inhibition of VgluT3+ interneurons and imaging of MCs/GCs (left). Experimental timeline for chemogenetic inhibition during contextual switching paradigm (right). C) Group data showing Ca 2+ transient frequency during baseline and C21 sessions for MCs and GCs (MCs: baseline, n=312 cells, 5 mice, C21 n=271 cells, 5 mice; GCs: baseline n=407 cells, 2 mice, C21 n=550 cells, 2 mice; ***p<0.001, **p<0.01 Mann-Whitney U test). D) Spatial heatmaps of MCs with a significant place field in either the familiar or novel context during baseline and C21 sessions. Cells were sorted by the peak of their spatial tuning curve in the familiar context. E) Group data showing tuning curve correlations for within context (FF) and between context (FN) comparisons during baseline and C21 sessions (baseline n=167 cells, 3 mice; C21 n=155 cells, 3 mice; ***p<0.001 Kruskal-Wallis test). F) Graph showing the average magnitude of difference in correlation (1′ stability) between FF and FN comparisons for baseline and C21 sessions (baseline n=167 cells, 3 mice; C21 n=155 cells, 3 mice; *p<0.05 t-test; mean± s.e.m.). G) Plot showing proportion of MCs baseline and C21 conditions that exhibit a decrease, increase or no change in tuning curve correlation from FF to FN (baseline n=167 cells, 3 mice; C21 n=155 cells, 3 mice).

    Article Snippet: For both hM3Dq and hM4Di experiments, mice received i.p. injections of DREADD agonist 21 (C21) (3 mg/kg; Tocris Cat No. 6422) 30 minutes before the start of imaging sessions.

    Techniques: Inhibition, Imaging, MANN-WHITNEY

    A) Example traces of GCaMP fluorescence traces from MCs (black, top), animal’s position in VR (gray, middle) and running velocity (green, bottom). Letters above position indicate environment type (Familiar - F or Novel - N) for each lap. B) Pie chart showing proportion of spatially tuned MCs in F, N or both environments during baseline and C21 conditions (baseline, n=243 cells, 3 mice; C21, n=201 cells, 3 mice). C) Average place field width for spatially tuned MCs during baseline and C21 conditions (baseline, n=243 cells, 3 mice; C21, n=201 cells, 3 mice). D) Graph showing activity-velocity correlation coefficient for MCs during baseline and C21 sessions. E) Histogram showing distribution of activity-velocity correlation lag during baseline and C21 sessions (baseline, n=243 cells, 3 mice; C21, n=201 cells, 3 mice)

    Journal: bioRxiv

    Article Title: A novel, evolutionarily conserved inhibitory circuit selectively regulates dentate gyrus mossy cell function

    doi: 10.1101/2025.07.09.663808

    Figure Lengend Snippet: A) Example traces of GCaMP fluorescence traces from MCs (black, top), animal’s position in VR (gray, middle) and running velocity (green, bottom). Letters above position indicate environment type (Familiar - F or Novel - N) for each lap. B) Pie chart showing proportion of spatially tuned MCs in F, N or both environments during baseline and C21 conditions (baseline, n=243 cells, 3 mice; C21, n=201 cells, 3 mice). C) Average place field width for spatially tuned MCs during baseline and C21 conditions (baseline, n=243 cells, 3 mice; C21, n=201 cells, 3 mice). D) Graph showing activity-velocity correlation coefficient for MCs during baseline and C21 sessions. E) Histogram showing distribution of activity-velocity correlation lag during baseline and C21 sessions (baseline, n=243 cells, 3 mice; C21, n=201 cells, 3 mice)

    Article Snippet: For both hM3Dq and hM4Di experiments, mice received i.p. injections of DREADD agonist 21 (C21) (3 mg/kg; Tocris Cat No. 6422) 30 minutes before the start of imaging sessions.

    Techniques: Fluorescence, Activity Assay